MAP - Market Access Podcast Podcast Por Dr. Stefan Walzer arte de portada

MAP - Market Access Podcast

MAP - Market Access Podcast

De: Dr. Stefan Walzer
Escúchala gratis

Acerca de esta escucha

 Market Access (or alternatively reimbursement) in health care is THE key competence in order to be commercially successful with a new drug, medical device or digital health application. However, given the fact that market access is a complex field involving various disciplines and is an ever-changing field, it is difficult to be up to speed with the different evolvements across the world. MAP is THE bi-weekly Market Access Podcast provided by MArS Market Access & Pricing Strategy, which is your health care consultancy in the German-speaking markets and allows you to keep up to date with market access , reimbursement and pricing issues in the D-A-CH countries and around the world. With MAP you will get a summary of core market access systems and processes as well as latest changes in regulations including statements and opinions of core decision makers and stakeholders from various countries. The CEO and founder of MArS is also the driver behind MAP: Dr. Stefan Walzer works in the field of payer strategy, pricing, health economics and reimbursement since 2004 and is the founder and CEO of MArS Market Access & Pricing Strategy GmbH based in Germany. MArS makes it as easy as possible for you to get your Pharmaceutical, MedTech or digital health product to the market and of course get the price it deserves. Stefan previously worked as a payer consultant for various global pharmaceutical and medical device / diagnostic companies, successfully launching their products across the world. He was the Global Payer Strategy Leader for various products and compounds at F. Hoffmann – La Roche AG, where he successfully developed early payer strategies as well as launching and maintaining the reimbursement process for top brands and early compounds. Stefan is capable in translating the clinical and economic evidence into successful reimbursement submissions and pricing negotiations especially in Austria, Germany and Switzerland. Additionally he teaches market access, pricing and negotiations at the State University of Baden-Wuerttemberg and the University of Applied Sciences Weingarten-Ravensburg (both Germany). Besides other roles and responsibilities. Stefan was the head of the committee “Inpatient care” of the German Health Economic Association (DGGÖ). Furthermore he is also a member of the Austrian Health Economic Association (ATHEA) and the Swiss Health Economic Association (SGGÖ). Additionally, he is a member of the Access Advisory Committee of the Global Pneumonia Prevention Coalition. Stefan received a Master of Science in Economics from the University of Tuebingen (Germany), a PhD in Health Economics from the University of Zurich (Switzerland) and a post-graduate diploma in Clinical Trials from the London School of Hygiene and Tropical Medicine (UK). He is co-author of more than 40 peer-reviewed scientific articles and more than 300 scientific abstracts.Copyright 2025 Dr. Stefan Walzer Ciencia Economía Enfermedades Físicas Hygiene & Healthy Living
Episodios
  • Is Cross-Functional Alignment the Secret to Successful Market Access, Kasem Akhras?

    Is Cross-Functional Alignment the Secret to Successful Market Access, Kasem Akhras?
    Jul 1 2025

    In this episode of the Market Access Podcast, Dr. Stefan Walzer sits down with Kasem Akhras, veteran access strategist and author of Frontiers in Market Access, to unpack what it really takes to bring innovative therapies to patients across emerging markets. From the rising demand for innovative therapies to the tightening grip of healthcare budgets, this episode explores the real challenges and opportunities in market access today.

    Discover why pricing strategies must be tailored to each market, how cross-functional collaboration and early planning are key to success, and how digital health and AI are reshaping the future of market access. A must-listen for anyone navigating the complexities of global market access.

    Stay updated for upcoming webinars through LinkedIn, and take the chance to stay connected through subscribing with your favorite podcasting platform or directly listen on our website: MAP Podcasts

    MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketaccess4-0.com/

    #MarketAccess #HealthEconomics #EmergingMarkets #PricingStrategy #PharmaInnovation #DigitalHealth #AIinPharma #marketaccess #marketaccesspodcast
    Más Menos
    38 m
  • How Do You Unlock the Power of Statistics in Market Access, Necdet Gunsoy?

    How Do You Unlock the Power of Statistics in Market Access, Necdet Gunsoy?
    Jun 15 2025

    Tune in to the latest episode of the Market Access Podcast, where Dr. Stefan Walzer welcomes statistician and Evimed founder Necdet Gunsoy to explore the critical role of statistics in health economics, HTA, and payer strategy. Learn how better collaboration between statisticians and market access teams can drive evidence-based decision-making, improve communication, and support strategic planning—plus the impact of AI on future workflows.

    This conversation spans key topics—from real-world evidence and health technology assessment (HTA) to internal cross-functional alignment and strategic planning in market access. Whether you're a health economist, market access leader, or data expert, this is a must-listen to improve cross-functional impact and efficiency.

    Stay updated for upcoming webinars through LinkedIn, and take the chance to stay connected through subscribing with your favorite podcasting platform or directly listen on our website: MAP Podcasts

    MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketaccess4-0.com/

    #MarketAccess #HealthEconomics #HTA #Pharma #PayerStrategy #marketaccess #marketaccesspodcast
    Más Menos
    36 m
  • How will AI shape the future of Market Access and Systematic Reviews, Jeffrey Johnson and Kevin Kallmes? (Repost)

    How will AI shape the future of Market Access and Systematic Reviews, Jeffrey Johnson and Kevin Kallmes? (Repost)
    Jun 1 2025

    This is a repost of a popular episode of MAP - Market Access Podcast, from July 15th 2024.

    Unlock the Future of Market Access with AI and Systematic Literature Reviews! Join Dr. Stefan Walzer in the latest episode of the Market Access Podcast as he delves into the transformative power of AI in systematic literature searches. Featuring Jeffrey Johnson and Kevin Kallmes from Nested Knowledge, this episode explores how their innovative platform revolutionizes literature reviews, making them faster, more efficient, and more enjoyable.

    This episode is for anyone who wants to learn more about the integration of AI in market access, reimbursement planning, and dossier creation. Tune in to find out how AI is not only saving time but also enhancing the quality of research and market access strategies. Don’t miss this insightful discussion on the future of AI in healthcare!

    Stay updated for upcoming webinars through LinkedIn, and take the chance to stay connected through subscribing with your favorite podcasting platform or directly listen on our website: MAP Podcasts

    MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketaccess4-0.com/

    #MarketAccess #AI #SystematicReview #HealthcareInnovation #Pharma #marketaccess #marketaccesspodcast
    Más Menos
    34 m
Todavía no hay opiniones